These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 26865139)

  • 1. Is one acceleromyographically measured train-of-four ratio sufficient after sugammadex to identify residual curarization in postoperative, awake patients?
    Unterbuchner C
    Br J Anaesth; 2016 Mar; 116(3):433-4. PubMed ID: 26865139
    [No Abstract]   [Full Text] [Related]  

  • 2. Sugammadex and residual neuromuscular block: what is acceptable normal practice?
    Todd MM
    Br J Anaesth; 2016 Mar; 116(3):434-5. PubMed ID: 26865140
    [No Abstract]   [Full Text] [Related]  

  • 3. Hidden universality of residual neuromuscular block.
    Eikermann M
    Br J Anaesth; 2016 Mar; 116(3):435-6. PubMed ID: 26865141
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of sugammadex on incidence of postoperative residual neuromuscular blockade: a randomized, controlled study.
    Brueckmann B; Sasaki N; Grobara P; Li MK; Woo T; de Bie J; Maktabi M; Lee J; Kwo J; Pino R; Sabouri AS; McGovern F; Staehr-Rye AK; Eikermann M
    Br J Anaesth; 2015 Nov; 115(5):743-51. PubMed ID: 25935840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fade of train-of-four ratio despite administration of more than 12 mg kg(-1) sugammadex in a myasthenia gravis patient receiving rocuronium.
    Kiss G; Lacour A; d'Hollander A
    Br J Anaesth; 2013 May; 110(5):854-5. PubMed ID: 23599531
    [No Abstract]   [Full Text] [Related]  

  • 6. The use of sugammadex in a patient with myasthenia gravis.
    Unterbuchner C; Fink H; Blobner M
    Anaesthesia; 2010 Mar; 65(3):302-5. PubMed ID: 20105151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sugammadex and rescue reversal.
    Mirakhur RK; Shields MO; de Boer HD
    Anaesthesia; 2011 Feb; 66(2):140-1; author reply 141. PubMed ID: 21254995
    [No Abstract]   [Full Text] [Related]  

  • 8. Reversal of rocuronium-induced (1.2 mg kg-1) profound neuromuscular block by accidental high dose of sugammadex (40 mg kg-1).
    Molina AL; de Boer HD; Klimek M; Heeringa M; Klein J
    Br J Anaesth; 2007 May; 98(5):624-7. PubMed ID: 17347184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sugammadex in a patient with Sjogren's syndrome and polymyositis.
    Carron M; Ieppariello G; Ori C
    Br J Anaesth; 2013 Dec; 111(6):1034-5. PubMed ID: 24233320
    [No Abstract]   [Full Text] [Related]  

  • 10. Sugammadex, a new reversal agent for neuromuscular block induced by rocuronium in the anaesthetized Rhesus monkey.
    de Boer HD; van Egmond J; van de Pol F; Bom A; Booij LH
    Br J Anaesth; 2006 Apr; 96(4):473-9. PubMed ID: 16464982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel approach to reversal of neuromuscular blockade.
    Della Rocca G; Pompei L
    Minerva Anestesiol; 2009 May; 75(5):349-51. PubMed ID: 19412157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The concept behind sugammadex.
    Epemolu O; Bom A
    Rev Esp Anestesiol Reanim; 2014 May; 61(5):272-6. PubMed ID: 24636599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized comparison of sugammadex and neostigmine for reversal of rocuronium-induced muscle relaxation in morbidly obese undergoing general anaesthesia.
    Gaszynski T; Szewczyk T; Gaszynski W
    Br J Anaesth; 2012 Feb; 108(2):236-9. PubMed ID: 22012861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversal of rocuronium-induced neuromuscular block with sugammadex is faster than reversal of cisatracurium-induced block with neostigmine.
    Flockton EA; Mastronardi P; Hunter JM; Gomar C; Mirakhur RK; Aguilera L; Giunta FG; Meistelman C; Prins ME
    Br J Anaesth; 2008 May; 100(5):622-30. PubMed ID: 18385265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do we really need sugammadex as an antagonist of muscle relaxants in anesthesia?
    Meistelman C; Donati F
    Curr Opin Anaesthesiol; 2016 Aug; 29(4):462-7. PubMed ID: 27168088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sugammadex reversal of rocuronium-induced neuromuscular block in Caesarean section patients: a series of seven cases.
    Pühringer FK; Kristen P; Rex C
    Br J Anaesth; 2010 Nov; 105(5):657-60. PubMed ID: 20736231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of sugammadex in patients with a history of pulmonary disease.
    Amao R; Zornow MH; Cowan RM; Cheng DC; Morte JB; Allard MW
    J Clin Anesth; 2012 Jun; 24(4):289-97. PubMed ID: 22608583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postoperative impairment of motor function at train-of-four ratio ≥0.9 cannot be improved by sugammadex (1 mg kg-1).
    Baumüller E; Schaller SJ; Chiquito Lama Y; Frick CG; Bauhofer T; Eikermann M; Fink H; Blobner M
    Br J Anaesth; 2015 May; 114(5):785-93. PubMed ID: 25586724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sugammadex in patients with myasthenia gravis.
    De Boer HD; Van Egmond J; Driessen JJ; Booij LHJD
    Anaesthesia; 2010 Jun; 65(6):653. PubMed ID: 20565409
    [No Abstract]   [Full Text] [Related]  

  • 20. Reversal of profound rocuronium-induced blockade with sugammadex: a randomized comparison with neostigmine.
    Jones RK; Caldwell JE; Brull SJ; Soto RG
    Anesthesiology; 2008 Nov; 109(5):816-24. PubMed ID: 18946293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.